drugset / Trial / NCT04470128
A Study Evaluating the Efficacy and Safety of HSK21542 Injection for Analgesia in Subjects Undergoing Colonoscopy
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a multi-center, randomized, two-stage, phase II clinical study .The main objective is to evaluate the safety and tolerability of HSK21542 injection for analgesia in patients undergoing colonoscopy, and, combining the pharmacodynamic (PD) and pharmacokinetic (PK) characteristics
Timeline
- Start
- 2020-08-19
- Primary completion
- 2020-12-28
- Completion
- 2021-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK21542 | Peptide | 0.5 ug/kg | Intravenous |
| Subject | HSK21542 | Peptide | 1 ug/kg | Intravenous |
| Subject | HSK21542 | Peptide | 2 ug/kg | Intravenous |
Indications
No indication recorded.